Dr. Glenn Haifer And Ampersand Capital Partners Acquire Australian Biologics Cdmo Luina Bio, Rebranding As Acurabio
Sep 07, 2022•about 3 years ago
Acquiring Company
Dr. Glenn Haifer
Acquired Company
Australian Biologics CDMO Luina Bio
Description
AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, a global healthcare private equity firm.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed